Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-14-062771
Filing Date
2014-10-24
Accepted
2014-10-24 14:42:55
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 v391811_424b3.htm 424B3 1229683
2 GRAPHIC tlogo.jpg GRAPHIC 7936
3 GRAPHIC image_001.jpg GRAPHIC 4436
  Complete submission text file 0001144204-14-062771.txt   1248034
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-196093 | Film No.: 141172126
SIC: 2834 Pharmaceutical Preparations